Back

Effect of finerenone on the incidence of hypokalemia in patients with type 2 diabetes and chronic kidney disease: a FIDELITY analysis

22 May 2023 (16:42 - 16:51)
Organised by: Logo
Congress Presentation Part of: Comorbidities Renal Failure and Cardiovascular Disease HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Professor Gerasimos Filippatos

National & Kapodistrian University of Athens Medical School, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
Lack of association between celiac disease and idiopathic dilated cardiomyopathy
Doctor G. Cediel Calderon (Tarragona, ES)
Abstract Slides Video
Presentation thumbnail
Implications of levels of hyperkalemia in the risk of renin-angiotensin-aldosterone system inhibitors interruption/down-titration and mortality in patients with chronic cardiovascular conditions
Doctor S. Jimenez-Marrero (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes - from the ESC Heart Failure Long-Term Registry
Assistant Professor A. Kaplon Cieslicka (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Haemodialysis in patients with cardiorenal syndrome: a review of hospital admissions and mortality
Doctor B. Leskovar (Trbovlje, SI)
Abstract Slides Video
Presentation thumbnail
Iron deficiency in heart failure - prevalence, symptoms, functional capacity and health-related quality of life, and outcomes according to different definitions
Mr F. Lindberg (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Comorbidities
Video

The Event

Event poster

Heart Failure 2023

22 May 2023 16:42 CET
You may be interested in
thumbnail
Congress Presentation
Effect of finerenone in patients with chronic kidney disease and type 2 diabetes by baseline anaemia status: a FIDELITY analysis
thumbnail
Congress Presentation
Discussant review - FINE-HEART
thumbnail
Congress Presentation
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by diuretic use: A FIDELITY analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources